The Biden administration proposed a change to the federal drug scheduling system on Thursday that it hopes will streamline research into Schedule I controlled substances including marijuana and psychedelics such as psilocybin. The White House Office of National Drug Control Policy (ONDCP) said in a letter to congressional leaders and a plan posted on the … Continue reading Biden’s Drug Czar Wants To Make It Easier To Research Marijuana, Psychedelics And Other Schedule I Substances